The Efficacy, Safety and Pharmacokinetic of Antiplatelet Therapy for Vicagrel

Clinical trial NCT03599284 · COMPLETED

Trial details

NCT number: NCT03599284
Sponsor: Jiangsu vcare pharmaceutical technology co., LTD
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Coronary Artery Disease Percutaneous Coronary Intervention Platelet Aggregation Inhibitors

Start date: 2018-08-30
Primary completion: 2019-06-11
Enrollment: 279

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.